Legal Opinion
GLAXOSMITHKLINE LLC v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
District Court, E.D. Pennsylvania
Decided September 3, 2020No. 2:19-cv-05321Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA GLAXOSMITHKLINE LLC, : Plaintiff, : v. : CIVIL ACTION NO. 19-5321 BOEHRINGER INGELHEIM : PHARMACEUTICALS, INC., : Defendant. : MEMORANDUM OPINION Rufe, J. September 3, 2020 Plaintiff GlaxoSmithKline LLC (“GSK”) seeks to preliminarily enjoin Defendant Boehringer Ingelheim Pharmaceuticals, Inc. (“BI”) from making certain marketing claims based on alleged violations of the Lanham Act’s prohibition on false advertising1 and Pennsylvania common law. BI opposes GSK’s request. After considering the parties’ briefings and…
2Cases cited34 opinions
- Zambelli Fireworks Manufacturing Co. v. WoodCourt of Appeals for the Third Circuit · 2010
- Colleen Reilly v. City of HarrisburgCourt of Appeals for the Third Circuit · 2017
- Kos Pharmaceuticals, Inc. v. Andrx Corporation Andrx Laboratories, IncCourt of Appeals for the Third Circuit · 2004
- Instant Air Freight Co. v. C.F. Air Freight, Inc.Court of Appeals for the Third Circuit · 1989
- Novartis Consumer Health, Inc. v. Johnson & Johnson-Merck Consumer Pharmaceuticals Co.Court of Appeals for the Third Circuit · 2002
29 more not listed; retrieve them via the Exa API.